Kyndryl Holdings, Inc. (KD) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by t ...

公司评级升级 - Ventyx Biosciences近期被Zacks评级系统上调至"强力买入"等级(Zacks Rank 1) 这一升级主要反映其盈利预期的上升趋势 而盈利预期是影响股价的最有力因素之一 [1] - Zacks评级系统的唯一决定因素是公司盈利预期的变化 该系统追踪卖方分析师对当前及未来年度每股收益(EPS)的共识预期(Zacks Consensus Estimate) [2] - 由于盈利预期的变化对短期股价走势具有强大影响力 Zacks评级系统对个人投资者尤为有用 相比华尔街分析师主观性较强的评级 Zacks系统更具实时可测量性 [3] 盈利预期与股价关系 - 公司未来盈利潜力的变化(通过盈利预期修正体现)与短期股价走势存在强相关性 这主要源于机构投资者根据盈利预期计算公司公允价值的行为模式 [5] - 对Ventyx Biosciences而言 盈利预期上升和评级升级意味着公司基本面改善 投资者对这种改善趋势的认可可能推动股价上涨 [6] - 实证研究显示 跟踪盈利预期修正趋势进行投资决策可能获得丰厚回报 Zacks评级系统正是有效利用了这一机制 [7] Zacks评级系统特征 - Zacks评级系统基于四项盈利预期相关指标 将股票分为五档(从Zacks Rank 1到5) 其1评级股票自1988年来年均回报率达+25% [8] - 该系统保持中性立场 在覆盖的4000多只股票中 "买入"和"卖出"评级比例均衡 仅前5%股票获"强力买入"评级 前20%股票显示其盈利预期修正优势 [10][11] Ventyx Biosciences具体数据 - 截至2025财年 公司预期每股亏损1.85美元 与上年持平 但过去三个月Zacks共识预期已上调6% [9] - 本次评级升级使Ventyx Biosciences进入Zacks覆盖股票的前5%行列 意味着该股近期可能呈现上涨趋势 [11]

State Street Corporation (STT) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.T ...

New Found Gold Corp. (NFGC) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Individual investors of ...

公司评级与投资价值 - Watts Water (WTS) 近期被上调至 Zacks Rank 1（强力买入），反映其盈利预期的上升趋势，这是影响股价的最强动力之一 [1] - Zacks 评级的唯一决定因素是公司盈利预期的变化，系统追踪当前及未来年度卖方分析师的每股收益（EPS）共识预期 [2] - 盈利预期的变化被证明与股价短期走势高度相关，机构投资者通过盈利预期计算公司股票的合理价值，进而影响买卖行为 [5] 盈利预期与业务改善 - Watts Water 的盈利预期上升和评级上调表明其基本面业务有所改善，投资者可能因此推高股价 [6] - 公司预计 2025 财年每股收益为 9.42 美元，与去年同期持平，但过去三个月 Zacks 共识预期已上调 2.9% [9] - 盈利预期修订趋势与股价短期波动的强相关性使得跟踪此类修订对投资决策具有重要价值 [7] Zacks 评级系统特点 - Zacks 评级系统基于盈利预期的四个因素将股票分为五类，其中 1 评级股票自 1988 年以来年均回报率达 +25% [8] - 该系统覆盖超过 4000 只股票，仅前 5% 获得“强力买入”评级，Watts Water 进入前 5% 表明其盈利预期修订表现优异 [10][11] - 与华尔街分析师的乐观倾向不同，Zacks 系统保持“买入”和“卖出”评级的均衡比例，增强其客观性 [10]

Investors might want to bet on Adial Pharmaceuticals, Inc. (ADIL) , as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following ...

Canada Goose (GOOS) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.The p ...

Geely Automobile Holdings Ltd. (GELYY) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is trac ...

Investors might want to bet on Astrana Health, Inc. (ASTH) , as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Since a c ...

Investors might want to bet on Cadence (CADE) , as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Since a changing e ...